About TFSCRO
TFSCRO is a Healthcare company based in Lund (Sweden) founded in 1996, and was acquired by Ratos in September 2015. Clinical research services are provided globally by TFS CRO. TFSCRO has completed 2 acquisitions, including Appletree CI Group and SCIderm. Its chief executive, as recorded, is Markus Granlund. Its website tfscro.com draws about 31 thousand monthly visits. TFSCRO offers products and services including Clinical Development, Resourcing Solutions, and Functional Services (FSP). Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service. Its legal entity is TFS TRIAL FORM SUPPORT INC.
Company details
TFS was founded in 1996 in Lund, Sweden, and operates as a mid-sized contract research organization in the pharmaceutical, biotech, and medical device sectors. Clinical research services are delivered to clients worldwide, including scientific advice, product development consulting, protocol design, regulatory affairs strategy, and interactions with global agencies. Assistance with submissions such as CTAIND and orphan drug designations is also offered, supporting operations across healthcare and life sciences.
- Investors
- Investments & AcquisitionsAppletree CI Group
& 1 more
- Acquired byRatos
(Sep 2015)
Products & Services of TFSCRO
TFSCRO offers a comprehensive portfolio of products and services, including Clinical Development, Resourcing Solutions, and Functional Services (FSP).
Services for clinical trial phases I-III and real-world evidence.
Flexible staffing for clinical projects and expertise support.
End-to-end clinical workforce management solutions.
Apps and channels of TFSCRO
its YouTube channel TFS HealthScience has 35 subscribers and 30 videos.
Videos from TFSCRO
The most watched videos on TFSCRO's YouTube channel, TFS HealthScience (35 subscribers). Click a video to play it here.
More on TFS HealthScience.
Investors in TFSCRO
TFSCRO has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Ratos.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity firm focused on consumer, industry, construction, and services sectors | 1866 | ratos.com | Stockholm, Sweden |
Investor details for TFSCRO
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of TFSCRO
88 people are tracked at TFSCRO (35 in leadership, 4 in board & advisors, 49 in team).
| Name | Role | Group |
|---|---|---|
Markus Granlund | CEO | Leadership |
Andrew Shala | Associate Director, Medical Writing | Leadership |
Simon Haile | Director Of Talent & Strategy, SRS | Leadership |
Miriam Martin | Vice President Of Business Development, CDS | Leadership |
Jordi Verdaguer Aligué | Senior Finance Business Partner | Leadership |
Jesper Hjort | CFO | Leadership |
Hanna Sandvall | VP, Strategic Resourcing Solutions | Leadership |
Patrik Darsund | Chief People Officer | Leadership |
Fotios Bililis | Financial Planning & Analysis Finance Business Partner | Leadership |
Elvira Szijarto | Medical Director Dermatology | Leadership |
Andreas Raaschou | Group Treasury, Senior Director | Leadership |
Liudmyla Rosvall | Head Of Finance | Leadership |
Yanis Merabet | Director, Business Development | Leadership |
Simone Völkle | Associate Director Regulatory Affairs | Leadership |
Harry Nadin | Global Head Of Talent Acquisition And UK Country Head | Leadership |
Tabitha Schlisserman | Director Of Business Development | Leadership |
Lucia Harviliková | Senior Finance Business Partner | Leadership |
Jorge Fernández | Director Of Business Development | Leadership |
Lakshmi Guduri | Senior Director Project Management ( Internal Medicine & Neuroscience Bu) | Leadership |
Aida Marín Pérez | Clinical Research Associate Contracted Partner Of Amgen | Leadership |
68 more people are available in the full profile.
Complete people profiles for TFSCRO
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by TFSCRO
TFSCRO has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Appletree CI Group and SCIderm.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
A contract research organization with experience in development of ophthalmology drugs and medical devices | appletree-cig.com | Winterthur, Switzerland | 2013 | Jan 2023 | •••• | |
CRO focussed exclusively in dermatology, allergology, aesthetic drug development and device certification services | sciderm.de | Hamburg, Germany | 2005 | Oct 2016 | •••• |
Complete acquisition details for TFSCRO
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of TFSCRO
4 dated milestones of TFSCRO across 27 years, from founding to its latest funding, stage changes and deals.
- Founded TFSCRO is founded.
- Exit Acquired by Ratos.
- Acquisition Acquires SCIderm.
- Acquisition Acquires Appletree CI Group.
Web traffic of TFSCRO
The website of TFSCRO (tfscro.com) receives about 30.9K visits a month and ranks #1,098,502 among all websites worldwide, #1,358 in Biotechnology and Pharmaceuticals.
- Monthly visits30.9K
▲ 13.6% vs previous month
- Unique visitors11.6K
per month
- Global rank#1,098,502
among all websites
- Category rank#1,358
Health · Biotechnology and Pharmaceuticals
- Bounce rate37%
- Pages per visit1.7
- Average visit32 sec
- DevicesDesktop 31% · Mobile 69%
Websites whose visitors overlap most with TFSCRO. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| altoida.com | 100% | 31.7K | #1,676,952 | View details | |
| efpia.eu | 84% | 89.3K | #445,999 | View details | |
| precisionformedicine.com | 83% | 36.8K | #1,000,701 | View details | |
| proclinical.com | 81% | 63.8K | #560,331 | View details | |
| novotech-cro.com | 77% | 49.2K | #897,361 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for TFSCRO
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Tfscro
Complete news archive for TFSCRO
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TFSCRO
TFSCRO was founded in 1996.
TFSCRO is headquartered in Lund, Sweden.
Markus Granlund is the CEO of TFSCRO, as recorded in our data.
TFS was founded in 1996 in Lund, Sweden, and operates as a mid-sized contract research organization in the pharmaceutical, biotech, and medical device sectors. Clinical research services are delivered to clients worldwide, including scientific advice, product development consulting, protocol design, regulatory affairs strategy, and interactions with global agencies. Assistance with submissions such as CTAIND and orphan drug designations is also offered, supporting operations across healthcare and life sciences.
TFSCRO offers Clinical Development, Resourcing Solutions, and Functional Services (FSP).
TFSCRO has made 2 acquisitions, including Appletree CI Group, and SCIderm.
TFSCRO has 1 investor. Key investors include Ratos.
TFSCRO operates through Tfs Trial Form Support Inc..
Yes. TFSCRO was acquired by Ratos in September 2015.